Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TMEM111 |
| Upstream (Parents) |
|---|
| (<<) SLC4A4 → TMEM111 |
| (<<) ACSS3 → TMEM111 |
| (<<) BTD → TMEM111 |
| (<<) PRR5L → TMEM111 |
| (<<) SDC3 → TMEM111 |
| (<<) GLYR1///SEPT6 → TMEM111 |
| (<<) PDCD6 → TMEM111 |
| Downstream (Children) |
|---|
| TMEM111 → DSC3 (>>) |
| TMEM111 → KLHL23 (>>) |
| TMEM111 → TMEM144 (>>) |
| TMEM111 → GABRB1 (>>) |
| TMEM111 → GPR22 (>>) |
| TMEM111 → PP14571 (>>) |
| TMEM111 → GPR15 (>>) |
| TMEM111 → CREM (>>) |
| TMEM111 → LRRC37A2///LRRC37A (>>) |
| TMEM111 → RSU1 (>>) |
| TMEM111 → FLJ11710 (>>) |
| TMEM111 → CD5 (>>) |
| TMEM111 → PDCD6 (>>) |
